CRP and irritable bowel syndrome: For example, patients with irritable bowel syndrome (IBS) treated with PMA-ZEO showed lower blood hsCRP (highly sensitive C reactive protein) levels and decreased stool α1-anti-trypsin levels, suggesting that PMA-ZEO might decrease systemic inflammation in humans.